Gastrointestinal (GI) cancers arise in the GI tract and accessory organs, including the mouth,
esophagus, stomach, liver, biliary tract, pancreas, small intestine, large intestine, and …

Background Ovarian cancer poses a serious threat to women's health. Due to the difficulty of
early detection, most patients are diagnosed with advanced-stage disease or peritoneal …

Background Drug resistance is a serious challenge in cancer treatment that can render
chemotherapy a failure. Understanding the mechanisms behind drug resistance and …

Cancer stem cells (CSCs) are a small subpopulation of tumor cells critical for tumor
development. Their unique abilities, such as self-renewal, have resulted in tumor resistance …

Lung adenocarcinoma, the most common histological subtype of non-small cell lung cancer,
exhibits heterogeneity that enables adaptability, limits therapeutic success, and remains …

Simple Summary Increasing evidence has revealed the regulatory roles of long non-coding
RNAs (lncRNAs) in the initiation and progress of oral squamous cell carcinoma (OSCC). As …

Abstract Background Super-enhancers (SEs), driving high-level expression of genes with
tumor-promoting functions, have been investigated recently. However, the roles of super …

As an important regulatory mechanism at the posttranscriptional level in metazoans,
adenosine deaminase acting on RNA (ADAR)-induced A-to-I RNA editing modification of …

Small extracellular vesicles (EVs) in the last 20 years are demonstrated to possess
promising properties as potential new drug delivery systems, biomarkers, and therapeutic …

Acquired docetaxel (doc) resistance, one of the major reasons for unfavorable prognosis in
patients with aggressive hormone-independent prostate cancer (HIPC), is a major obstacle …